The Motley Fool

2 high-growth stocks I’d buy for 2018 and beyond

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Arrowings ascending on a chalkboard
Image source: Getty Images.

Befitting its rather dull core business of storing documents in huge warehouses, the recent success of Restore (LSE: RST) seems to have flown under the radar of many retail investors. But because of the necessity of its core business for a variety of professional industries, from accountants to solicitors, Restore has returned nearly 400% to investors over just the past five years.

Judging by the firm’s year-end trading update released this morning, these index-walloping returns could be set to continue for a long time to come. This is because the company continues to build on its market-leading position in document management while also consolidating the fragmented markets for related professional services such as document shredding, IT asset disposal and toner recycling.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

The trading update provided no firm figures but disclosed the business was continuing to make good progress and that sales, profits and earnings per share would all be significantly ahead of last year. This is no surprise when considering the company’s H1 results, in which organic growth and acquisitions led to revenue rising 57% to £86.9m and EBITDA increasing 59% to £19.5m.

Looking forward, I wouldn’t be surprised if this level of top line growth slowed significantly in 2018 as Restore’s management focuses on integrating a slew of recent acquisitions and works to lower net debt levels of around 2x EBITDA. But with plenty of scope to improve margins and cash flow, and also plenty of acquisition targets out there in a fragmented industry, I believe now could be an interesting point to begin a stake in Restore at a sane valuation of 22 times forward earnings.

Growth has never tasted so sweet

Another high-growth stock I’ve got my eye on is speciality ingredients manufacturer Treatt (LSE: TET), whose share price has risen 420% over the past decade. This growth has been driven by management repositioning the business as an innovation-led developed of flavours and scents used in everything from tea to soap and haircare products.

And within this overarching category of speciality ingredients, Treatt has benefitted immensely from its expertise in all natural citrus flavours. Sales of these ingredients have been rocketing in recent years as consumers have shifted towards preferring all natural ingredients in their drinks as well as less sugar, another area in which Treatt has expertise.

Management has built the company’s expertise in these areas into a major selling point for winning new contracts with global fast moving consumer goods firms. This is clear in the group’s results for the year to September, with revenue up 24.5% to £109.6m, and operating profits up 44.6% to £13.8m as margins rose significantly.

There’s good reason to believe this level of growth is entirely sustainable as Treatt moves deeper into the massive US market. The group already has a manufacturing facility there but a recent £21.6m fund-raising with institutional investors will provide the capital to expand and modernise facilities in the US and UK to support accelerating sales growth.

Treatt’s impressive record of success, double-digit margin improvements and growth opportunities mean its shares aren’t traditionally cheap at 24.7 times forward earnings. But with plenty of room to further exploit its niche positions, no debt and rising dividends, I think Treatt could continue to richly reward shareholders.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.